Rapid corticosteroid tapering in acute eosinophilic pneumonia

Outcomes of rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001352

Enrollment

Registered

2015-01-19

Start date

2014-08-19

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia) : Acute eosinophilic pneumonia patients with initial normal peripheral eosinophil count were tr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with acute eosinophilic pneumonia 1) an acute onset of febrile respiratory manifestations 25% eosinophils in bronchoalveolar lavage or eosinophilic pneumonia evident on lung biopsy, and, 4) absence of any known cause of pulmonary eosinophilia, including drug abuse, toxin exposure, or infection.

Exclusion criteria

Exclusion criteria: Patients who were not diagnosed with acute eosinophilic pneumonia

Design outcomes

Primary

Measure	Time frame
Treatment failure: clinical deterioration after stopping corticosteroid treatment	—

Secondary

Measure	Time frame
Time to overall clinical stabilization from diagnosis;Time to complete resolution of all symptoms and clinical instabilities from diagnosis;Adverse events during corticosteroid treatment;Durations of additional medications to relieve adverse effects	—

Countries

Korea, Republic of

Contacts

Public ContactByung Woo Jhun

Armed Forces Capital Hospital

Outcome results